| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 203.75B | 216.38B | 242.89B | 240.35B | 179.91B |
| Gross Profit | 31.54B | 33.73B | 37.17B | 34.24B | 25.64B |
| EBITDA | 11.33B | 12.75B | 14.88B | 13.03B | 8.86B |
| Net Income | 7.84B | 8.88B | 9.99B | 8.78B | 5.08B |
Balance Sheet | |||||
| Total Assets | 162.21B | 157.60B | 163.35B | 143.75B | 108.05B |
| Cash, Cash Equivalents and Short-Term Investments | 7.62B | 8.38B | 6.87B | 6.54B | 5.13B |
| Total Debt | 29.43B | 42.63B | 52.10B | 45.65B | 29.48B |
| Total Liabilities | 108.45B | 108.59B | 117.16B | 104.75B | 76.03B |
| Stockholders Equity | 52.83B | 47.86B | 45.04B | 37.85B | 30.95B |
Cash Flow | |||||
| Free Cash Flow | 15.41B | 17.36B | -602.00M | -12.46B | -1.27B |
| Operating Cash Flow | 15.68B | 18.91B | 301.00M | -12.19B | -891.00M |
| Investing Cash Flow | 1.20B | -2.07B | -2.69B | -199.00M | -155.00M |
| Financing Cash Flow | -17.85B | -15.25B | 2.53B | 13.75B | 606.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥18.54T | 24.82 | 12.80% | 0.78% | 10.40% | 11.67% | |
78 Outperform | ¥316.82B | 8.42 | ― | 2.04% | -6.70% | -48.47% | |
75 Outperform | ¥1.08T | 19.48 | 11.14% | 1.46% | 4.32% | 6.72% | |
72 Outperform | ¥108.00B | 7.75 | ― | 3.02% | -5.84% | -10.06% | |
71 Outperform | ¥1.11T | 15.41 | 15.75% | 1.08% | 17.94% | 48.64% | |
62 Neutral | ¥483.72B | 19.19 | 5.63% | 2.35% | -12.89% | -47.51% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |